Timing of surgical intervention for the intact primary in stage IV breast cancer patients

Annals of Surgical Oncology

Volumn 15, Issue 6, 2008, Pages 1696-1702

  Rao, Roshni ^a   Feng, Lei ^b   Kuerer, Henry M ^b   Singletary, S Eva ^b   Bedrosian, Isabelle ^b   Hunt, Kelly K ^b   Ross, Merrick I ^b   Hortobagyi, Gabriel N ^b   Feig, Barry W ^b   Ames, Frederick C ^b   Babiera, Gildy V ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast surgery; Stage IV; Surgical timing

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; TAMOXIFEN; TRASTUZUMAB;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CAUCASIAN; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FOLLOW UP; HORMONAL THERAPY; HUMAN; METASTASIS; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE PROGRESSION; FEMALE; HUMANS; MASTECTOMY; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 43449124083     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9830-4     Document Type: Article

References (9)

1. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002; 132:620-7
2. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006; 13:776-82
3. Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 2000; 87:881-6
4. Singletary SE, Allred C, Ashley C, et al., Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003; 83:803-19
5. Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metastases: trends in survival during a 14 year period. J Clin Oncol 2004; 22:3302-8
6. Polite BN, Olopade OI. Breast cancer and race: a rising tide does not lift all boats equally. Perspect Biol Med 2005; 48(Suppl):166-75
7. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567-75.
8. Kinoshita T, Takasugi M, Iwamoto E, et al. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 2006; 191:225-9
9. Norton L. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. The Oncologist 2005; 10:370-81